Oseltamivir efficacy, side effects, and safety in children with influenza |
Seo, Eun Sun
(Department of Pediatics, Busan St. Mary's Medical Center)
Park, Geun Hwa (Department of Pediatics, Busan St. Mary's Medical Center) Kim, Sung Mi (Department of Pediatics, Busan St. Mary's Medical Center) Kim, Sung Won (Department of Pediatics, Busan St. Mary's Medical Center) Jung, Woo Sik (Department of Pediatics, Busan St. Mary's Medical Center) Cho, Kyung Soon (Institute of Health & Environment) Park, Yeon Gyeong (Institute of Health & Environment) Lee, Chang Kyu (Department of Laboratory Medicine, Anam Hospital of Korea University Medical Center) Kang, Chun (Department of Influenza, Centers for Disease Control and Prevention) Lee, Joo Yeon (Department of Influenza, Centers for Disease Control and Prevention) Choi, Woo Young (Department of Influenza, Centers for Disease Control and Prevention) |
1 | World Health Organization (WHO). Influenza A (H1N1) virus resistance to oseltamivir. 2008/2009 influenza season, northern hemishere. Weekly Epidemiological Record 2009.3.18 |
2 | Centers for Disease Control and Prevention. Update: influenza activity; United Statates, 1996-97 season. MMWR 1997;46:76-8, 173-6 |
3 | Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG, Soo W, et al. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 1989;321:1696-702 DOI PUBMED ScienceOn |
4 | Nicholson KG, Aoki FY, Osterhaus AD, Trottier S, Carewicz O, Mercier CH, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000;355:1845-50 DOI PUBMED ScienceOn |
5 | Anthony E, David K, Karen B. Prevention and control of influenza: Recommendation of the Advisory Committee on Immunization Practices (ACIP) 2008. MMWR 2008;Early Release:1-60 |
6 | Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 2004;364:759-65 DOI ScienceOn |
7 | Matheson NJ, Harnden AR, Perera R, Sheikh A, Symmonds-Abrahams M. Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database Syst Rev 2007;1:CD002744 PUBMED |
8 | Smith JR, Sacks S. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment. Int J Clin Pract 2009;63:596-605 DOI ScienceOn |
9 | Long M. Side effects of Tamiflu: clues from an Asian single nucleotide polymorphism. Cell Res 2007;17:309-10 DOI PUBMED ScienceOn |
10 | Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 2008;52:3284-92 DOI ScienceOn |
11 | Wiely DC, Skehel TT. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus infection. Ann Rev Biochem 1987;56:365-94 DOI ScienceOn |
12 | Glezen WP. Influenza and hospitalizations in children. N Engl J Med 2000 ;342:1752-3 DOI ScienceOn |
13 | Lee PY, Matchar DB, Clements DA, Huber J, Hamilton JD, Peterson ED, et al. Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Ann Intern Med 2002;137:225-31 DOI PUBMED ScienceOn |
14 | Mitamura K, Sugaya N, Nirasawa M, Shinjoh M, Takeuchi Y. Effectiveness of oseltamivir treatment against influenza type A and type B infection in children. Kansenshogaku Zasshi 2002;76:946-52 DOI PUBMED |
15 | Na SH, Park SE, Park JY, Lee HJ. Epidemiology of Influenza Virus over 8 Years (1990-1998) in Seoul, Korea. Korean J Infect Dis 1999;31:210-16 DOI ScienceOn |
16 | Munoz FM. The impact of influenza in children. Semin Pediatr Infect Dis 2002;13:72-8 DOI PUBMED ScienceOn |
17 | Hyden FG, Gwaltney JM, Van de castle RL, Adams KF. Compare toxicity of amantadine hydrochloride and rimantadine chloride in healthy adults. Antimicrob Agents Chemother 1981;19:226-33 PUBMED ScienceOn |
18 | Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet 2000;355:827-35 DOI ScienceOn |
19 | Gu J, Xie Z, Gao Z, Liu J. Oseltamivir: neuropsychiatric disorders. Prescrire Int 2007;16:200 PUBMED |
20 | Carlsen KH, Halvorsen K. Viral infections of the respiratory tract in hospitalized children: study from Oslo during a 90-month period. Acta Pediatr Scand 1983;72:53-8 DOI |
21 | Influenza Sentinel Surveillance Report 2008.5.25 www.cdc.go.kr |
22 | Englund JA. Antiviral therapy of influenza. Semin Pediatr Infect Dis 2002;13:120-8 DOI PUBMED ScienceOn |
23 | Dubravska cesta. New concerns about oseltamivir. Lancet 2007;369:1056 PUBMED |
24 | Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000;181:831-7 DOI ScienceOn |
25 | Treanor JJ, Hayden FG, Vrooman PS, Barbarash R. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000;283:1016-24 DOI ScienceOn |
26 | Schmidt AC. Antiviral therapy for influenza: a clinical and economic comparative review. Drugs 2004;64:2031-46 DOI PUBMED ScienceOn |
27 | Richard J, Frederick G, Hayden, Keith S. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis 2001;30:127-33 DOI ScienceOn |
28 | Influenza Sentinel Surveillance Report 2009.3.8 www.cdc.go.kr |